Better molecules, by design
Powered by Science, Enriched by AI. Trusted by you
Cresset helps discovery teams generate smarter ideas, make stronger decisions, and design better molecules. Our AI-enriched simulation science solutions bring computational and medicinal chemists together to streamline discovery from target validation to candidate selection.










Robust science with results you can rely on
Accelerate Lead Optimisation with Active Learning FEP

saving compute time needed to generate FEP results
> 0 %
increased success rate by nearly
0 x
Robust science with results you can rely on
Accelerate Lead Optimisation with Active Learning FEP

saving compute time needed to generate FEP results
>80%
increased success rate by nearly
2.5x
Novel molecule generation
ligand designs generated in Spark
0

selected for synthesis Activity: 2nM to 2.4µM
0

candidate series for development
1

Digital molecular discovery solutions enriched by AI
Your trusted partner for digital molecular discovery
Trusted by the scientific community
Journal of Medicinal Chemistry
Sean M. Carney et al.
In Silico Research in Biomedicine
B.R, Bharath, Sreerupa Mitra, Nadeem Khan
npj Drug Discovery
Gul I, Isham IM et al.
Pest Management Science
Victoria Jackson, Chris Sherer, Linda Jordan, Thomas Clohessy
Journal of Medicinal Chemistry
Dutheuil, G. et al.
News & Events
Cresset are exhibiting at BiotechX Europe in Switzerland in October. Meet the team at booth 107 and explore how you can improve your current drug discovery workflows.
Find out what's new in Flare™ V12 in our latest webinar with significant enhancements to FEP and structure-based methods
We're exhibiting at this year's EuroQSAR. Pass by the stand to speak to the team and learn more about how Cresset computational and AI drug discovery solutions can help you accelerate your projects.
Cresset is sponsor of the next Ai in Drug Discovery Xchange in San Francisco. Don't miss the chance to meet the team and attend our round table on lead generation and optimization.
Cresset releases Flare V12, a new version of its computer-aided drug design (CADD) solution for the discovery, design and optimization of small molecules. Flare V12 is focussed on improving access to Free Energy Perturbation (FEP) in drug discovery.
Cresset is a sponsor at the upcoming EFMC-ISMC event in Basel. Come and see us at stand 10 to discuss how Cresset's software solutions can improve your drug discovery workflows.
Cresset Discovery has delivered a highly efficient digital workflow combining their molecular modeling expertise with Cresset technology to accelerate discovery, design and optimization of a METTL3 inhibitor.
Subscribe & Don't Miss Out
Receive our newsletter to be among the first to hear about product releases, case studies, opinion articles, events and more.












